In 2027, 28,697 new cases of blood cancer or haematological cancer will be diagnosed in Spain, among which are mainly leukemias, lymphomas or multiple myelomas. This will keep these neoplasms as the fifth most common cancer group in Spain, only behind tumors of breast, lung, prostate and colon. Together, they will represent approximately 10% of new diagnoses. The five-year survival of all haematological neoplasms is 63%, with better results in w…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
In 2027, 28,697 new cases of blood cancer or haematological cancer will be diagnosed in Spain, among which are mainly leukemias, lymphomas or multiple myelomas. This will keep these neoplasms as the fifth most common cancer group in Spain, only behind tumors of breast, lung, prostate and colon. Together, they will represent approximately 10% of new diagnoses. The five-year survival of all haematological neoplasms is 63%, with better results in w…